Epidarex Capital closes new fund

Country

United Kingdom

Epidarex Capital, the Edinburgh, UK-based venture capital firm, has closed a new fund to support early-stage UK life science companies. The fund raised £102.1 million at the close, of which £50 million represents a commitment from Enterprise Capital Funds, a government-supported scheme to help the growth of young businesses.